Loading…
the sparker alert will let you know when a significant move starts with an audio alert, so You'll never miss an Opportunity.
Xbiotech Inc Is A Biopharmaceutical Company That Discovers And Develops True Human Monoclonal Antibodies Derived From Human Donors To Replicate The Human Immune Response In The Treatment Of Various Diseases. It Has Developed A Pipeline Of Product Candidates Using True Human Antibodies Targeting Both Inflammatory And Infectious Diseases. The Company'S Developement Pipeline Comprises: Natrunix, An Antibody Targeting Il-1a In Oncology (Pancreatic Cancer), A Clinical Stage Therapeutic For Methicillin Resistant Staphylococcus Aureus (Mrsa), And Several Pre-Clinical Stage Therapeutics, Including: An Oral Delivery Antibody Therapeutic For Colon Infection By C. Difficile; An Injectable Therapy For Varicella Zoster (Adult Chicken Pox), The Causative Agent For Shingles; And An Influenza Therapy.